These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18184235)

  • 21. [Conditions of the prevention of neonatal hemolytic diseases resulting from Rh(D) incompatibility in Hungary].
    Simonovits I; Garancsy L; Böröcz I
    Orv Hetil; 1980 Apr; 121(15):875-8. PubMed ID: 6770319
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe neonatal hemolysis due to a maternal antibody to the low-frequency Rh antigen C(w).
    May-Wewers J; Kaiser JR; Moore EK; Blackall DP
    Am J Perinatol; 2006 May; 23(4):213-7. PubMed ID: 16596484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemolytic disease of the newborn and therapeutic anti-allergic antibodies].
    Guimbretière J; Dehorne M; Guimbretière L
    Rev Fr Transfus; 1969; 12(1):Suppl:395+. PubMed ID: 4987784
    [No Abstract]   [Full Text] [Related]  

  • 24. [A case of hemolytic disease in newborns caused by antiagglutinins E (RH)].
    Argirov A; Mikhova M
    Vopr Okhr Materin Det; 1968 Oct; 13(10):71-2. PubMed ID: 4976398
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemolytic disease of the newborn caused by anti-D with factor Du in the mother].
    Brandstädter W; Brandstädter M
    Zentralbl Gynakol; 1970 Feb; 92(6):176-8. PubMed ID: 5001845
    [No Abstract]   [Full Text] [Related]  

  • 26. Severe intrauterine hemolysis due to anti-C(w).
    Chu HP; Kanagalingam D; Chan DK
    Am J Perinatol; 2007 Nov; 24(10):623-6. PubMed ID: 17972235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anti-Rh immunoglobulin (D) subclasses and hemolytic disease of the newborn].
    Cregut R; Pinon F; Brossard Y
    Nouv Presse Med; 1973 Jul; 2(29):1947. PubMed ID: 4198948
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neonatal thrombopenia and hemolytic disease of the newborn due to Rh incompatibility].
    Malinvaud G; Borie R
    Rev Fr Transfus; 1969; 12(1):Suppl:277-90. PubMed ID: 4987779
    [No Abstract]   [Full Text] [Related]  

  • 29. Extensive restrictions in the VH sequence usage of the human antibody response against the Rhesus D antigen.
    Andersen PS; Haahr-Hansen M; Coljee VW; Hinnerfeldt FR; Varming K; Bregenholt S; Haurum JS
    Mol Immunol; 2007 Jan; 44(4):412-22. PubMed ID: 16581131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemolytic disease of the newborn due to alloimmunization as a consequence of multiple transfusions and a delayed hemolytic transfusion reaction in the mother.
    Kanra T; Erdoğan S; Yurdakök M; Erdem G
    Turk J Pediatr; 1983; 25(2):129-33. PubMed ID: 6422599
    [No Abstract]   [Full Text] [Related]  

  • 31. Rare case of hemolytic death of the newborn due to anti-hr0 and anti-e.
    Gong Y; Ai Y; Zhou R
    J Obstet Gynaecol Res; 2011 May; 37(5):465-7. PubMed ID: 21208345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn.
    Sacks DA; Nance SJ; Garratty G; Petrucha RA; Horenstein J; Fotheringham N
    Am J Perinatol; 1993 Nov; 10(6):428-31. PubMed ID: 8267805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhesus anti-E, anti-c antibodies as a cause of hemolytic disease of the newborn.
    Nair PM; Sabarinathan K; Jayaprakash PA; Vijayalekshmi
    Indian Pediatr; 1983 Sep; 20(9):681-4. PubMed ID: 6427106
    [No Abstract]   [Full Text] [Related]  

  • 35. [Possibility of errors in the determination of the genotype Rh in newborn infants with fetal erythroblastosis].
    Cavallini R
    Riv Emoter Immunoematol; 1968; 15(3):83-8. PubMed ID: 4980459
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of Rh hemolytic disease by passive immunization.
    Hart GD
    Appl Ther; 1967 Apr; 9(4):372-4. PubMed ID: 4962682
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of antibody titer and its response to therapy prior to using technics with greater risk in perinatal hemolytic disease].
    De Araujo JJ
    Rev Clin Inst Matern Lisb; 1967; 18(70):257-71. PubMed ID: 4299386
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hemolytic diseases of the newborn in Japan].
    Shirakawa M
    Nihon Sanka Fujinka Gakkai Zasshi; 1971 Aug; 23(8):730-40. PubMed ID: 4999292
    [No Abstract]   [Full Text] [Related]  

  • 39. Non-"D" rhesus and irregular antibodies--an approach to management.
    Dornan KJ
    Ir Med J; 1982 Mar; 75(3):79-82. PubMed ID: 6804410
    [No Abstract]   [Full Text] [Related]  

  • 40. [Complement factors C'1-C'4) in maternal and infant serum in Rh-dependent hemolytic disease of newborn].
    Tacke A; Schneeweiss B; Ullrich E; Ijaiya K
    Padiatr Grenzgeb; 1972; 11(5):381-5. PubMed ID: 4200376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.